Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Daiichi Pharmaceutical Co. Ltd.

Division of Daiichi Sankyo Co. Ltd.
www.daiichipharm.co.jp

Latest From Daiichi Pharmaceutical Co. Ltd.

Life After White Oak: Hamburg’s Predecessors Offer Glimpse At Where Pharma Might See Her Again

In interviews with “The Pink Sheet,” the last half-dozen FDA commissioners discuss crafting policy on Capitol Hill, building start-up biotechs, consulting and serving on industry boards.

BioPharmaceutical North America

McKinsey To Advise On Global Integration Between Sun, Ranbaxy

Global consulting firm McKinsey is tasked with creating an integration roadmap between Sun Pharma and Ranbaxy, the two Indian generic giants that leaped to the fifth rank in the global generics pecking order with a deal announced in April.

BioPharmaceutical Asia Pacific

Hikma To Buy Bedford, Transfer Manufacturing For U.S. Generics Injectables

Ben Venue’s shuttered Ohio plant is also slated to be part of the transaction, but Hikma’s initial focus is on moving acquired assets into its production facilities, even though the Jordan-based firm expects only limited revenue from them over the next two years.

BioPharmaceutical United States

Sun Pharma Set For Bumpy Drive To Reach Ranbaxy

Analysts are growing cautious on the mega Sun-Ranbaxy deal, raising doubts on the timelines for regulatory approvals and the fallout of court proceedings. Some have questioned if an open bidding process could have been followed to win a higher value for Ranbaxy shareholders.

BioPharmaceutical India
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • Daiichi Sankyo Co. Ltd.
  • Senior Management
  • Tadashi Suzuki, Chmn. & CEO
    Hiroyuki Nagasako, Sr. Managing Dir., Fin. & Admin.
    Thomas G Burger, VP, Bus. Dev.
    Kiyoshi Morita, Pres.
  • Contact Info
  • Daiichi Pharmaceutical Co. Ltd.
    Phone: (81) 32720611
    14-10 Nihonbashi 3-Chome, Chuo-Ku
    Tokyo, 103-8234
    Japan
Advertisement
Advertisement
UsernamePublicRestriction

Register